Pathologic complete response in HER2-positive breast cancer patients receiving trastuzumab in neoadjuvant setting

Fareeha, Sheikh; Adil, Nazir; Samia, Yasmeen; Farhana, Badar; Usman, Ahmad; Neelam, Siddiqui.

JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2019; 29 (2): 159-163

in English | IMEMR | ID: emr-202931

ABSTRACT

Objective:

To compare the pathological complete response in human epidermal growth factor receptor type 2 [HER-2] positive breast cancer patients getting neoadjuvant chemotherapy with or without trastuzumab

Search on Google

Index: IMEMR (Eastern Mediterranean) Language: English Journal: J. Coll. Physicians Surg. Pak. Year: 2019

MEDLINE

LILACS

LIS

Search on Google

Index: IMEMR (Eastern Mediterranean) Language: English Journal: J. Coll. Physicians Surg. Pak. Year: 2019